Next Article in Journal
Application of Biomaterials in Diabetic Wound Healing: The Recent Advances and Pathological Aspects
Previous Article in Journal
Oral Gel Formulation of Cotinus coggygria Scop. Stem Bark Extract: Development, Characterization, and Therapeutic Efficacy in a Rat Model of Aphthous Stomatitis
Previous Article in Special Issue
Design, Synthesis, In Vitro and In Silico Biological Evaluation of New Pyridine-2,5-Dicarboxylates Esters Bearing Natural Source Fragments as Anti-Trypanosomatid Agents
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Use of Metabolomics Approach in the Discovery of Active Compounds from Macroalgae Laurencia Species Against Schistosomiasis

by
Amanda Beatriz Silva Soares
1,2,3,
Patricia Aoki Miyasato
1,
Rafaela Paula de Freitas
1,
Adolfo Luis Almeida Maleski
4,
Daniel Carvalho Pimenta
5,6,
Pio Colepicolo
2,
Erika Mattos Stein
2,
Arthur Ladeira Macedo
7,
Carlos Alexandre Carollo
7 and
Eliana Nakano
1,3,*
1
Laboratory of Parasitology, Butantan Institute, São Paulo 05503-900, SP, Brazil
2
Laboratory of Biochemistry and Molecular Biology of Marine Algae, Chemistry Institute, University of Sao Paulo, São Paulo 05508-090, SP, Brazil
3
Interunits Postgraduate Program in Biotechnology (PPIB), Institute of Biomedical Sciences, University of Sao Paulo, São Paulo 05508-000, SP, Brazil
4
Experimental Morphophysiology Laboratory, Natural and Humanities Sciences Center (CCNH), Federal University of ABC (UFABC), São Bernardo do Campo 09606-070, SP, Brazil
5
Laboratory of Biochemistry, Butantan Institute, São Paulo 05503-900, SP, Brazil
6
Ecology and Evolution Laboratory, Butantan Institute, São Paulo 05503-900, SP, Brazil
7
Laboratory of Natural Products and Mass Spectrometry—LaPNEM, Faculty of Pharmaceutical Sciences, Food and Nutrition, Federal University of Mato Grosso do Sul, Campo Grande 79070-900, MS, Brazil
*
Author to whom correspondence should be addressed.
Pharmaceutics 2025, 17(10), 1294; https://doi.org/10.3390/pharmaceutics17101294
Submission received: 1 July 2025 / Revised: 1 September 2025 / Accepted: 17 September 2025 / Published: 2 October 2025
(This article belongs to the Special Issue Advances in Antiparasitic Agents)

Abstract

Background: Marine macroalgae has been studied by our research group as alternative sources of bioactive compounds with promising antiparasitic activity, particularly against Schistosoma mansoni. Objectives: This study aimed to employ a metabolomics-based approach to identify anthelminthic active compounds from the macroalgae Laurencia aldingensis Saito and Womersley 1974 and Laurencia dendroidea J. Agardh 1852. Methods: The algae were extracted using a dichloromethane/methanol mixture, followed by liquid–liquid partitioning and sequential chromatographic fractionation using solvents of varying polarities. The resulting fractions were tested for biological activity against adult Schistosoma mansoni worms. Detailed chemical characterization of the extracts was conducted via HPLC-DAD-MS/MS, with subsequent data alignment and statistical analysis (Pearson correlation) to associate specific chemical compounds with the observed bioactivity. Results: Non-polar fractions (hexane and dichloromethane) exhibited significant anthelminthic activity, substantially reducing parasite viability and reproduction. Specific subfractions obtained from the dichloromethane fraction demonstrated notable activity. Metabolomic analysis revealed considerable chemical diversity, emphasizing the presence of bromophenols and halogenated sesquiterpenes, including potentially novel compounds with therapeutic potential against schistosomiasis. Conclusions: The metabolomics approach proved effective in identifying promising bioactive compounds from Laurencia spp. macroalgae with activity against S. mansoni.

Graphical Abstract

1. Introduction

Bioguided fractioning has been traditionally used in bioprospection studies to isolate and identify active compounds. Despite the simplicity and low cost, the technique is not always effective, especially if not directed to specific classes of already known active compounds. Crude extracts of natural origin are complex biological matrices with, not rarely, several active compounds, requiring sophisticated and advanced analytical methods to target bioactive metabolites [1]. The complexity of highlighting active metabolites may represent an even greater challenge for non-fully explored natural sources, such as marine macroalgae, when compared to plant species.
The potential of macroalgae as a source of bioactive compounds for neglected diseases has yet to be thoroughly explored [2]. Schistosomiasis remains an important public health problem affecting about 250 million people worldwide [3]. As for the other neglected diseases, the chemical arsenal to the control of schistosomiasis is limited to few drugs raising concern with the emergence of resistance [4,5]. Within this context, our group has been working on bioprospection studies with Brazilian macroalgae to identify compounds of potential use in the treatment and control of schistosomiasis. In a preliminary screening, 13 crude extracts were tested for activity on Schistosoma mansoni [6]. In a following and more comprehensive study, 45 crude extracts obtained from 37 species were screened for molluscicidal activity against Biomphalaria glabrata embryos and antischistosomal activity against S. mansoni, identifying 22 species (60%) with activity in at least one of the two models [7]. Species selected in the trial step were further assessed for the isolation and identification of active compounds through bioguided fractionation. Three halogenated monoterpenes and the sesquiterpene elatol were identified as the compounds responsible for the antiparasitic and molluscicidal activities observed for the red macroalgae Ochtodes secundiramea and Laurencia dendroidea [8,9]. These results highlight the potential of seaweeds as a source of novel bioactives for schistosomiasis control.
Alternatively to the bioguided fractionation, we employed a metabolomic approach to annotate active compounds directly from the crude extracts tested in the screening study on S. mansoni and B. glabrata [7]. The data from the GC–MS analysis along with those from the biological activity were subjected to correlation tests to point the main hits. However, due to the chemical complexity, the metabolomic analysis was performed with taxonomically related groups presenting at least three active extracts and three inactive/relatively inactive extracts, resulting in the establishment of two sets—Ochrophyta and Laurencia/Laurenciella. Therefore, the constitution of sets for statistical analysis allowed for the alignment of the data despite the chemical complexity of the species studied. In this way, we were able to analyze the chemical compositions and biological activities interdependence and identify the most promising hits. The Pattern Hunter test was used to list these hits, and the heatmap permitted a closer look at the distribution pattern of these compounds in the extracts, contributing to an initial classification of the promising hits.
For the present study, Laurencia aldingensis and L. dendroidea, Rhodophyta species which demonstrated to be a potential source of both antischistosomal and molluscicidal compounds and integrated the Laurencia/Laurenciella set in our previous studies were selected [7,9].
Aiming a more efficient and direct separation of metabolites from the complex macroalgal matrix in the pre-analytical stage, a meticulously refined extraction protocol was used. Moreover, the metabolomics-based approach allowed not only to point hits, but also to identify possible synergistic interactions among different classes of compounds.

2. Materials and Methods

2.1. Experimental Design

A crude extract was initially obtained with a dichloromethane/methanol (1:1, v/v) combination and submitted to a liquid–liquid partition. The resulting dichloromethane phase was submitted to a sequential fractionation based on the solvent’s polarities: hexane, dichloromethane, ethyl acetate, and methanol.
The resulting fractions were assessed for antischistosomal activity at 100, 75, 50, 25 µg/mL with praziquantel 1.5 μg/mL as positive control and DMSO 1.5% μg/mL as negative control. The antiparasitic activity was monitored for 96 h for the effects on motility and reproduction and classified based on a score system as: No effect (0–10), Poor (11–37), Regular (38–80), and Good (81–150).
The dichloromethane fractions of both species were subfractioned on a HPLC—LC RID and assessed for biological activity and analyzed by HPLC-MS/MS for metabolomic approach.

2.2. Algae Sampling

The algae samples of Laurencia dendroidea and L. aldingensis samples were in Espírito Santo State, Southeastern Brazil and a voucher of representative specimens were deposited at the Maria Eneyda P. Kauffmann Fidalgo Herbarium (SP) at the Instituto de Botânica in São Paulo—L. dendroidea (voucher: SP 399.936) and L. aldingensis (voucher: SP 400.203). After collection, the fresh algae were washed thoroughly with seawater to remove sand particles and epiphytes. The cleaned material was stored frozen in zip-lock plastic bags at −20 °C until preparation of the extracts.

2.3. Obtention of Extracts, Fractions and Subfractions

After lyophilization and grinding, extracts were obtained by maceration of the material with dichloromethane and methanol 1:1 for 48 h, filtered, and concentrated under reduced pressure. The process was repeated 5 times to the obtention of 1200 mL of crude extract from L. dendroidea and 600 mL from L. aldingensis. Next, a liquid–liquid partition was performed by adding ultrapure water at 1:1:1 to the obtention of the hydromethanolic and dichloromethane phase. After adsorbed in silica, the dichloromethane phase was submitted to a sequential fractioning with hexane, dichloromethane, ethyl acetate and methanol. A volume of 450 mL of each solvent was used for L. dendroidea and 200 mL for L. aldingensis; all fractions were concentrated on a rotary evaporator.
The dichloromethane fractions of both species were subfractioned on a HPLC—LC RID—20 (Shimadzu®, Kyoto, Japan) high efficiency liquid chromatograph with a reverse column C8 (250 × 4.6 mm × 5 µm). The mobile phase consisted of ultrapure water (solvent A) and acetonitrile 90% (solvent B) each mixed with 0.1% formic acid (v/v). trifluoracetic acid 0.1%. The gradient elution profile was programmed as follows: an initial period of 0–5 min with 40% solvent B, followed by a linear increase from 40% to 100% solvent B over 5–40 min, remaining at 100% solvent B between 40 and 50 min. Following a linear decay from 100% to 40% solvent B over 50–55 min. Post-gradient, the column underwent a 5 min wash and reconditioning phase. The flow rate was 1 mL/min, with an injection volume of 200 µL.
Detection parameters included ultraviolet (UV) monitoring at the wavelengths of 214–254 nm with manual injection and collection.
For L. dendroidea, 7 subfractions were obtained from 84.2 mg and 7 subfractions from 71.5 mg for L. aldingensis; fractions were collected 10 times.

2.4. HPLC-DAD-MS/MS Analyses

All extracts and fractions were initially solubilized in a methanol and water mixture (7:3, v/v) at uniform concentrations. Following solubilization, the solutions were filtered using a 0.22 µm PTFE syringe filter. Analytical procedures were conducted using a Shi-madzu LC-20AD system (Shimadzu, Kyoto, Japan), integrated with a diode array detector and an ESI-qTOF mass spectrometer (MicroTOF-Q III, Bruker Daltonics, Billerica, Billerica, MA, USA).
Chromatographic separation was achieved on a highly efficient Kinetex® C-18 column (2.6 μm, 150 × 2.2 mm, Phenomenex®, Torrance, CA, USA), safeguarded by a corresponding pre-column. The column was maintained at 50 °C during the analysis. The mobile phase consisted of ultrapure water (solvent A) and acetonitrile (solvent B), each mixed with 0.1% formic acid (v/v).
The gradient elution profile was programmed as follows: an initial 0–2 min period with 3% solvent B, followed by a linear increase from 3% to 25% solvent B over 2–25 min, culminating in a ramp from 25% to 80% solvent B between 25 and 40 min. Post-gradient, the column underwent an 8 min washing and reconditioning phase. The flow rate was 0.3 mL/min, with an injection volume of 1 µL.
Detection parameters included ultraviolet (UV) monitoring across a broad wave-length range of 240 to 800 nm. The mass spectrometer operated in both negative and positive ionization modes, covering a mass-to-charge ratio (m/z) range of 120–1.200. A capillary voltage of 4500 V was applied, with nitrogen serving as the nebulizer gas at 4 bar and as the drying gas at a flow rate of 9 L/min. Data were processed using DataAnalysis 4.2 software (Bruker Daltonics, Billerica, MA, USA).

2.5. Metabolomic Approach

HPLC-MS/MS data were processed using MetaboAnalyst 6.0 on the HPLC-Q/TOF platform in negative mode. Spectra were converted to centWave-features, and peaks were aligned by quality-control-based retention–time correction (minFraction = 0.8) with contaminant removal. QC samples were used to correct retention differences and maintain data quality. The resulting peak matrix included extracts and fractions. Intensities were median normalized across samples, log10 transformed to reduce skewness and Pareto scale. Pattern–search correlation analysis was performed using the Score as the reference pattern and Pearson correlation as the distance measure. Methodology and parameter selection follow the MetaboAnalyst guidelines and Pang et al. [10].

2.6. Schistosomicidal Activity in Adult Worms

The life cycle of S. mansoni (Sambon, 1907) (Trematoda: Schistosomatidae) (BH strain—Belo Horizonte, MG, Brazil) was maintained in Biomphalaria glabrata (Say, 1818) (Gastropoda: Planorbidae) snails and female hamsters Mesocricetus auratus (Waterhouse, 1839) (Mammalia: Cricetidae) aged 4 weeks, freshly weaned, weighing 50–60 g, were housed in cages (30 × 20 × 13 cm) containing a sterile bed of wood shavings.
Each biological activity experiment used 4 female hamsters infected by subcutaneous injection of 300 cercariae, and six weeks later, S. mansoni adult worms were recovered by perfusion of the rodent’s portal and mesenteric system. The in vitro activity assay was performed according to a protocol established in our laboratory as previously described [6,7,9]. Shortly, adult worms were recovered through portal perfusion from hamsters 42 days after infection. Five coupled male and female worms were exposed to the test compounds; praziquantel was used as the positive control and DMSO as the negative control. Worms were maintained in 24-well culture plates at 37 °C and 5% CO2 and monitored after 2 h and then every 24 h thereafter for 96 h for motility, morphological alterations, and reproduction.

2.7. Score Construction

The anthelminthic activity was assessed by visual scoring of motility alterations. Scoring ranged from 0 to 150 with the higher values indicating major alterations. To ease interpretation, score values were classified and assigned to four categories according to the extent of effects: The category “Poor” scored 11–37 and includes worms with no or slight alterations on motility; “Regular” scored 38–80 displaying features intermediary between categories “Poor” and “Good”, which were worms with the no detectable movements and “No effects” scored 0–10 was attributed to groups with low % of worms with no or slight alterations on motility (Table 1).

3. Results and Discussion

In a previous study, we combined metabolomic approaches with analytical techniques to point out potential anthelminthic and molluscicide compounds in 45 crude extracts from 37 Brazilian seaweed species [7]. Multivariate analysis pointed towards 8 hits for molluscicidal activity and 33 hits for anthelminthic activity. After investigation based on published data, previous knowledge from chromatographic analysis and spectroscopic annotation of isolated compounds, triquinane alcohols, prenylated guaianes, dichotomanes, and xenianes were highlighted as potential active compounds. However, due to the high chemical complexity of the data, the metabolomic analysis was performed with taxonomically related groups that presented at least three active extracts and three inactive/relatively inactive extracts. Thus, the present study concentrated on refining the pre-analytical step of the protocol, aiming to generate fractions with reduced complexity and minimal overlap of metabolites.
The crude extracts were previously submitted to a liquid–liquid partition to the obtention of the dichloromethane phase. After comprehensive fractioning with solvents of different polarities, a wide range of metabolites with good resolution was obtained from the dichloromethane phase, contrasting with the complex data from the previous study. Non-polar to polar compounds were eluted subsequently according to solvent gradient, resulting in a clearer spectrum of chemical profile. Still, an additional fractionation step through HPLC-MS/MS was performed to the dereplication.
The crude extracts from the two selected macroalgae species Laurencia aldingensis and L. dendroidea were obtained with dichloromethane and methanol 1:1. Next, a liquid–liquid partition of the crude extract of L. dendroidea resulted in 1.840 mg (4.19%) of dichloromethane phase and 3.430 mg (7.80%) of hydromethanolic phase. The crude ex-tract of L. aldingensis resulted in 1.700 mg (4.69%) of dichloromethane phase and 2.720 mg (7.51%) of hydromethanolic phase.
The resulting dichloromethane phase was, therefore, submitted to a comprehensive fractioning of with solvents of different polarities, hexane, dichloromethane, ethyl acetate and methanol. For L. dendroidea, the hexane fraction resulted in 220 mg (12.94%), ethyl acetate fraction produced 420 mg (24.71%), dichloromethane fraction, 550 mg (32.35%) and the methanol fraction produced 550 mg (32.35%). For L. aldingensis, hexane fraction yielded 70 mg (4.11%), ethyl acetate, 290 mg (17.05%), dichloromethane fraction, 470 mg (27.64%), and methanolic fraction produced 240 mg (14.11%).

3.1. Biological Activity: Scoring Framework

The assessment of schistosomicidal activity has been based on phenotypical analysis [11,12,13]. However, despite being the gold standard in the evaluation of effects on schistosomes, subtle variations on biological effects are not detected. This gap was partially fulfilled with a score-based assessment [14,15,16,17], which still is not comprehensive enough, as the effects are scored at the end of the experiment within a narrow range and it does not allow to attribute a numerical value for a quantitative analysis. Still, to be inserted in a data matrix to a multivariate analysis, a numerical value must be attributed to biological effects. Usually, IC50 values are chosen to represent a biocide effect, but it is impossible to measure the wide range of subtle toxic effects at non-lethal doses. Therefore, in order to improve the score-based assessment, our group established a cumulative score, calculated throughout the experiment, resulting in a wider range (0–150) to measure the biological effects. Based on the obtained values, samples were classified in four categories, Poor (11–37), Regular (38–80), Good (81–150), and No Effects (0–10). Our results showed that L. aldingensis (Table 2) and L. dendroidea (Table 3) significantly affected viability and reproduction of exposed adult S. mansoni worms.
For L. aldingensis, the anthelminthic activities of hexane and dichloromethane fractions were classified as Good according to the score values—120 and 115, respectively, at 100 µg/mL. At 75 µg/mL, the dichloromethane activity was still classified as Good, but it decreased to Poor at the lowest concentration. On the other hand, the activities of methanol and aqueous fractions were classified as Poor, with score values of 10, 20 and 16; ethyl acetate was classified as no effect.
For Laurencia dendroidea (Table 2), the hexane fraction showed the highest activity, reaching a score of 139 with 100 µg/mL, being classified as Good. The dichloromethane fraction activity was classified as Regular, with score values of 80 and 40 with 100 µg/mL and 75 µg/mL, respectively, and Poor with score values of 37 at 50 µg/mL and 14 at 25 µg/mL. Etil acetate and methanol fractions activity was classified as Poor, with score values of 26 and 22; the hydromethanolic phase scored zero.

3.2. Biological Activity: Subfractions

As described in 2.3, dichloromethane fractions of both Laurencia species were submitted to the fractionation in HPLC at analytical scale. The fractions were collected according to the retention time and peak grouping, resulting in a total of 7 fractions for L. dendroidea and 7 fractions for L. aldingensis. From 84.2 mg of the dichloromethane fraction of L. dendroidea, a similar yield of all fractions was obtained, except for DCM—F4, which resulted in 30.5 mg (36.22%). From 71.5 mg of L. aldingensis, a similar yield was obtained for all the fractions.
The analysis of effects on viability and reproduction of S. mansoni showed that the subfractions of dichloromethane fraction were active against adult worms (Table 4 and Table 5). For Laurencia aldingensis (Table 4), subfractions DCM-F4 and DCM-F5 activity with 100 µg/mL and 75 µg/mL being classified as Good according to the score values; at 50 µg/mL and 25 µg/mL concentrations, the activity was scored as Poor or Regular (F4).
For Laurencia dendroidea, dichloromethane fractions DCM-F3, DCM-F4 and DCM-F6 induced 100% mortality. However, only DCM-F4 at 100 µg/mL was scored as Good, inducing 100% mortality after 24 h of exposure; at 75 µg/mL and 50 µg/mL, DCM-F4 was scored as regular.

3.3. Metabolite Profiling

The metabolites analysis of Laurencia aldingensis by HPLC-DAD-MS/MS (Figure 1, Table 6) reveals a complex chemical spectrum. Beginning with the compounds identified in peaks 4 to 7, a series of bromophenols was observed, including 5-bromo-3,4-dihydroxybenzaldehyde, and 3,5-dibromo-4-hydroxybenzoic acid—compounds known for their antioxidant properties [18,19]. The presence of these metabolites is characteristic of the Laurencia genus and suggests a defensive or signaling role against pathogens and herbivores in the marine environment [20,21]. These compounds are also of interest in the search for novel bioactive molecules with pharmacological potential.
Continuing the analysis, several peaks—namely 8, 9, 10, 12, 13, 14, 18, 19, 23, 24, and 29—could not be identified based on their molecular formulas or observed fragment ions. These compounds share the presence of both bromine and chlorine atoms in their structures and the absence of previously isolated substances matching their molecular formulas, suggesting that they may represent novel compounds not yet reported in scientific literature. For a specific subset—peaks 18, 19, 23, and 24—data indicated a possible structural analogy with halogenated sesquiterpenes of the aldigenin type, previously isolated from Laurencia aldingensis [22,23]. It is worth noting that the occurrence of halogenated structures is recurrent among red algal metabolites [24,25]. The possibility that these are new natural products highlights the relevance of future studies aimed at their isolation and full structural characterization, which could unveil new chemical entities and contribute to our understanding of marine biodiversity and its adaptive mechanisms.
The compound identified at peak 16, furocaespitanelactol—a member of the furocespitane class—is particularly intriguing, as it exhibits structural similarities to molecules previously reported in both algae and mollusks, suggesting the existence of a potentially conserved biosynthetic pathway [26,27,28]. Such pathways may be associated with symbiotic interactions or adaptations to specific ecological niches in the marine environment.
Hydroxylated fatty acids, such as those observed at peaks 20 and 22, represent a class of compounds that perform a variety of cellular functions, including membrane formation and signaling. These fatty acids are important structural components in algae and have implications for both algal physiology and its interactions with the surrounding environment [29,30]. Finally, peak 35 suggests a lobophorolide derivative, indicating the presence of long chain polyketides in Laurencia aldingensis. Polyketides are a class of secondary metabolites characterized by complex structures and a wide range of biological functions, ranging from chemical defense to the attraction of symbionts [31,32,33]. In summary, the data highlights the chemical complexity of L. aldingensis. The study of these compounds paves the way for a better understanding of the complex ecological interactions of this seaweed, as well as for the development of novel biotechnological and pharmaceutical resources. Mass spectrometry serves as a crucial tool for unraveling the chemical and biological complexity of these organisms, and each identified peak represents a potential starting point for future discoveries.
The data discussed above refers to the set of metabolites observed in the extracts of L. aldingensis. In the following section, we provide a more detailed discussion of the distribution of these compounds across the extracts and partitions presented in Figure 1, Table 6.
The hydromethanolic phase obtained through partitioning (Figure 1L. aldingensis—Hydromethanolic phase), in which compound 1 and other highly polar compounds are prominent, as evidenced by their shorter retention times on the C18 column—indicating high affinity for water and the likely presence of polar functional groups. This fraction also contains polyketide 35, which was not detected in the other partitions, suggesting that the initial partitioning was effective in enriching this compound.
The hexane fraction was enriched in hydrophobic compounds, as evidenced by the prominent presence of peak 16 (furocaespitanelactol) and the more apolar aldingenin derivatives (peaks 23 and 29). In contrast, the dichloromethane (DCM) fraction exhibited a broader range of peaks, likely reflecting its ability to elute a wider spectrum of hydrophobic metabolites due to its relatively low polarity. Here, we observed a certain selectivity for furocaespitanelactol (peak 16) and aldingenin derivatives (peaks 18, 19, 23, 24, and 29), consistent with the expectation that DCM favors the extraction of compounds with higher hydrophobicity. This fraction also contained bromophenolic derivatives (peaks 4 to 7).
In the ethyl acetate fraction, compound 16 (furocaespitanelactol) and sesquiterpenoid structures related to the aldingenin skeleton, such as peaks 18 and 19, were prominent. These compounds suggest the presence of more complex and moderately polar structures that retain some solubility in this solvent. This indicates that these molecules possess structural features allowing moderate interactions with the silica stationary phase, favoring their elution with solvents of intermediate polarity.
Finally, the methanolic fraction was enriched in more polar metabolites. Specifically, compounds 21 (C26H40O11) and 25 (C28H44O11), although not fully characterized, share similar molecular formulas, suggesting they belong to the same class of compounds. Figure 2 presents subfractions F1–F7, obtained through additional C8 column fractionation of the dichloromethane fraction (L. aldingensis—DCM). It highlights the capacity of reversed-phase chromatography to discriminate molecules based on polarity and their affinity for the hydrophobic stationary phase.
In the original L. aldingensis—Dichloromethane fraction, we observed a wide array of compounds, including peaks 4, 5, 6, 7, 13, 14, 16, 18, 19, 23, 24, and 29. These represent a mixture of bromophenols, terpenoids, and other apolar compounds, as indicated by their respective retention times.
With refinement through reversed-phase fractionation, a clear segregation of components began to emerge. Subfraction DCM—F1 retained many of the more polar compounds from the original mixture, as evidenced by peaks 4, 5, and 6. This suggests that these metabolites exhibit moderate interaction with the C8 stationary phase and are eluted with less apolar solvents in the mobile phase.
Subfractions DCM—F2 and DCM—F3 began to show a shift toward more apolar compounds, such as peak 16 (furocaespitanelactol), which appears consistently across multiple fractions. The persistent presence of this compound suggests a significant affinity for the C18 stationary phase, requiring a stronger elution gradient to be displaced from the column, or alternatively, that it is present at high concentration, saturating the system and appearing in several subfractions.
Moving to subfractions DCM—F4 through DCM—F7, we observed a progressive decrease in compound diversity. In particular, DCM—F5 and DCM—F6 were predominantly composed of column related contaminants; however, it is also possible that these subfractions contain non-ionizable compounds that were not detected under the current MS conditions. Peak 16 remained dominant, and peak 29 occurred in DCM—F7, suggesting that this compound requires more specific elution conditions, possibly due to its higher hydrophobicity or larger molecular size.
These results illustrate the principle that reversed-phase C8 chromatography can be fine-tuned to separate compounds based on subtle differences in polarity and solubility. With appropriate optimization of the elution gradient, compounds such as furocaespitanelactol and aldingenin derivatives—which may possess biological or pharmaceutical relevance—can be effectively isolated for further analysis.
The Pearson correlation analysis (Figure 3) clearly highlights specific chemical compounds highly associated with the observed anthelminthic activity in fractions of Laurencia aldingensis. Notably, compounds annotated as Peak 30, Peak 29, Unknown_108, Unknown_106, and Unknown_107 demonstrated strong positive correlations (correlation coefficient > 0.7). Boxplots provided below the correlation graph further emphasize that these metabolites exhibit substantially higher intensities in active fractions compared to inactive ones, reinforcing their potential key role in the observed biological activity.
Furthermore, the unknown metabolites (Unknown_106, Unknown_107, and Unknown_108) also display high correlation, likely representative of novel bioactive compounds not previously reported. Future research focusing on the isolation, characterization, and biological evaluation of these metabolites is critical and could significantly advance therapeutic strategies against schistosomiasis. Conversely, metabolites showing negative correlations (e.g., Unknown_28, Unknown_48, Unknown_51) may serve as negative chemical markers to streamline and optimize bioactivity guided purification protocols.
Chromatographic analysis by HPLC-DAD-MS/MS revealed a high chemical diversity in fractions from Laurencia dendroidea, comparable to that observed in L. aldingensis (Figure 4 and Figure 5). The dichloromethane fraction was selected for subfractionation due to its remarkable activity and its shared compounds with other fractions.
Major compounds in this fraction included oxygenated sesquiterpenes, fatty acid derivatives, and halogenated metabolites (Table 7). Peaks 8 and 10 were annotated as laurecomin D and hydroxy laurecomin D, while Peaks 2, 7, 8, and 11 presented fragmentation patterns and molecular formulas consistent with yet undescribed sesquiterpenoid derivatives.
Among fatty acid derivatives, Peak 29 was identified as hydroxy eicosanoic acid [34]. Peaks 22 and 23 were annotated as penicitide A isomers, a polyketide previously isolated from Penicillium chrysogenum, an endophytic fungus associated with Laurencia species [35]. Peak 30 was identified as the marine-derived steroid muristeroid G [36].
Chromatographic profiles of subfractions F1–F7 (Figure 4), obtained from the dichloromethane fraction via reverse-phase C8 column, showed effective separation by polarity. More polar compounds were concentrated in the initial subfractions, while less polar compounds were found in later ones. Several peaks absent or at low intensity in the original fraction became enriched in the subfractions, highlighting the efficiency of the chromatographic process.
Statistical analysis revealed that several LC-MS peaks showed a significant positive correlation (p < 0.05) with biological activity against Schistosoma mansoni (Figure 6).
One of most notable was penicitide A (23, r = 0.744; p = 0.0056), which was exclusive to active fractions. Other significantly correlated peaks included 11 (r = 0.799; p = 0.0018), 12 (r = 0.723; p = 0.0078), and 27 (r = 0.704; p = 0.011), all being halogenated compounds. Additionally, laurecoin D (8, r = 0.808; p = 0.0015) and hydroxy laurecomin D (10, r = 0.800; p = 0.0018) also showed strong correlations with biological activity. Both are halogenated sesquiterpenes previously reported in Laurencia composita [37].
The strong correlation between schistosomicidal activity and penicitide A (23) suggests a direct involvement of these compounds in the biological effect of Laurencia dendroidea. Penicitide A belongs to a class of polyketides previously reported for antimicrobial properties, although its activity against Schistosoma mansoni has not yet been described [35]. The exclusive presence of 23 in active fractions supports its potential as a bioactive lead compound.
Peaks 11, 12, and 27, annotated as halogenated but uncharacterized molecules, also showed positive correlations with biological activity. The presence of bromine and chlorine atoms in their structures is consistent with typical metabolites from the Laurencia genus, which are known for their biochemical diversity and broad pharmacological potential. Halogenated marine natural products have been associated with enzyme inhibition and disruption of membrane integrity in helminths [38].
Sesquiterpenes such as laurecomin D and its hydroxylated derivative (10 and 8) also showed high correlation coefficients. These compounds have been previously described in Laurencia composita with antimicrobial and cytotoxic activities [37]. While their role in schistosomicidal activity remains to be confirmed, their presence in active fractions suggests potential involvement (Figure 6).
The observed diversity of compounds and their distribution across fractions and subfractions suggests that the schistosomicidal effect may result from synergistic interactions among different classes of metabolites, particularly halogenated sesquiterpenes and fatty acid derivatives. This pattern is consistent with findings in L. aldingensis, where bioactivity has also been linked to chemical synergy.
Overall, these results underscore the pharmacological potential of Laurencia dendroidea as a source of novel schistosomicidal agents. Further work is needed to isolate and structurally characterize the peaks most strongly correlated with activity—especially the penicitide A—and to evaluate their bioactivity through in vitro and in vivo assays. The elucidation of yet uncharacterized halogenated metabolites (e.g., 11, 12, and 27) may also lead to the discovery of new marine-derived bioactive scaffolds.

4. Conclusions

In conclusion, this study successfully demonstrates the effectiveness of a refined metabolomics-based approach in identifying promising bioactive compounds from Laurencia aldingensis and L. dendroidea with significant schistosomicidal activities. The optimized extraction and fractionation procedures generated samples of reduced chemical complexity and minimal metabolite overlap, enabling precise and robust chemical characterization via high-resolution mass spectrometry (HRMS). The observed chemical diversity and the distinct distribution patterns across fractions and subfractions strongly indicate that the anthelminthic activity may arise from synergistic interactions among multiple classes of metabolites, particularly halogenated sesquiterpenes and fatty acid derivatives.
The significant correlations identified through statistical analysis highlighted several metabolites—such as bromophenols, halogenated sesquiterpenes, and potentially novel bioactive structures—as primary candidates underlying the observed antiparasitic effects. Laurencia dendroidea, in particular, emerges as a valuable source of novel schistosomicidal agents. Future research should prioritize the isolation, structural elucidation, and comprehensive pharmacological evaluation of these highly correlated compounds, specifically focusing on promising candidates such as penicitide A. Additionally, the characterization of previously unidentified halogenated metabolites (e.g., peaks 11, 12, and 27) could provide novel marine-derived chemical scaffolds with significant therapeutic potential. Overall, advancing the understanding of these marine macroalgal metabolites not only contributes to marine biodiversity knowledge and chemical ecology but also represents an essential step toward developing innovative treatments for schistosomiasis.

Supplementary Materials

The following are available online at https://www.mdpi.com/article/10.3390/pharmaceutics17101294/s1, S1: Schistosomicidal effect of marine macroalgae Laurencia aldingensis Y. Saito and Womersley 1974 fractions on Schistosoma mansoni worms. S2: Schistosomicidal effect of marine macroalgae Laurencia dendroidea J. Agardh 1852 fractions on Schistosoma mansoni worms. S3: Schistosomicidal effect of marine macroalgae Laurencia aldingensis Y. Saito and Womersley 1974 subfractions on Schistosoma mansoni worms. S4: Schistosomicidal effect of marine macroalgae Laurencia dendroidea J. Agardh 1852 subfractions on Schistosoma mansoni worms. S5: List of entries used in the statistical correlation analyses between compounds detected in the HPLC-MS chromatograms (negative ion mode) and the schistosomicidal activity score. S6: List of entries used in the statistical correlation analyses between compounds detected in the HPLC-MS chromatograms (negative ion mode) and the schistosomicidal activity score. S7: Schistosomicidal Activity in Adult Worms: Animal care and monitoring.

Author Contributions

Conceptualization, E.N., C.A.C. and A.L.M.; formal analysis, C.A.C. and A.L.M.; data curation, E.N., D.C.P. and A.B.S.S.; funding acquisition, P.C., E.N. and D.C.P.; investigation, A.B.S.S., P.A.M., R.P.d.F., A.L.A.M. and E.M.S.; methodology, E.N., C.A.C. and A.L.M.; project administration, E.N.; resources, E.N. and P.C.; supervision, E.N.; validation, A.B.S.S., P.A.M., R.P.d.F. and A.L.A.M.; visualization, A.B.S.S., E.N., C.A.C. and A.L.M.; writing—original draft, A.B.S.S., D.C.P., E.N., C.A.C. and A.L.M.; writing—review and editing, E.N., C.A.C. and A.L.M. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by: FAPESP (Fundação de Amparo a Pesquisa do Estado de São Paulo), grant number 2016/06931-4 to P.C.; CNPq (Conselho Nacional de Desenvolvimento Científico e Tecnológico), grant number 305525/2023-9 to D.C.P. and Fundação Butantan.

Institutional Review Board Statement

The animal study protocol was approved by the Ethics Committee of Butantan Institute (protocol code CEUA Nº 5042140818—15 August 2018).

Data Availability Statement

The original contributions presented in the study are included in the article/Supplementary Material; further inquiries can be directed to the corresponding author.

Acknowledgments

We are grateful to Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) for providing the fellowships to the post-graduation student A.B.S.S (Process: 131318/2021-7 and 141465/2024-7).

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Wolfender, J.L.; Marti, G.; Thomas, A.; Bertrand, S. Current approaches and challenges for the metabolite profiling of complex natural extracts. J. Chromatogr. A 2015, 1382, 136–164. [Google Scholar] [CrossRef]
  2. Falkenberg, M.; Nakano, E.; Zambotti-Villela, L.; Zatelli, G.A.; Philippus, A.C.; Imamura, K.B.; Velasquez, A.M.A.; Freitas, R.P.; Tallarico, L.d.F.; Colepicolo, P.; et al. Bioactive compounds against neglected diseases isolated from macroalgae: A review. J. Appl. Phycol. 2019, 31, 797–823. [Google Scholar] [CrossRef]
  3. Lo, N.C.; Bezerra, F.S.M.; Colley, D.G.; Fleming, F.M.; Homeida, M.; Kabatereine, N.; Kabole, F.M.; King, C.H.; Mafe, M.A.; Midzi, N.; et al. Review of 2022 WHO guidelines on the control and elimination of schistosomiasis. Lancet Infect. Dis. 2022, 22, e327–e335. [Google Scholar] [CrossRef] [PubMed]
  4. Gryseels, B.; Polman, K.; Clerinx, J.; Kestens, L. Human schistosomiasis. Lancet 2006, 368, 1106–1118. [Google Scholar] [CrossRef]
  5. Doenhoff, M.J.; Hagan, P.; Cioli, D.; Southgate, V.; Pica-Mattoccia, L.; Botros, S.; Coles, G.; Tchuem Tchuente, L.A.; Mbaye, A.; Engels, D. Praziquantel: Its use in control of schistosomiasis in sub-Saharan Africa and. Parasitology 2009, 136, 1825–1835. [Google Scholar] [CrossRef] [PubMed]
  6. Stein, E.M.; Machado, L.P.; Roffato, H.K.; Miyasato, P.A.; Nakano, E.; Colepicolo, P.; Andreguetti, D.X. Antischistosomal activity from Brazilian marine algae. Rev. Bras. Farmacogn. 2015, 25, 663–667. [Google Scholar] [CrossRef]
  7. Stein, E.M.; Tajú, S.G.; Miyasato, P.A.; de Freitas, R.P.; Tallarico, L.F.; Dos Santos, G.S.; Luiz, G.L.F.; Rofatto, H.K.; da Silva, F.N.V.; Colepicolo, P.; et al. The Prospective Use of Brazilian Marine Macroalgae in Schistosomiasis Control. Mar. Drugs 2021, 19, 234. [Google Scholar] [CrossRef] [PubMed]
  8. Tajú, S.G.; Stein, E.M.; Nakano, E.; Colepicolo, P. Uso de compostos Octodenos Halogenados na Preparação de um Medicamento para Prevenção e/ou Tratamento de Esquistossomose e para Aplicação em Águas Infestadas por Caramujos E Cercárias; República Federativa do Brasil—Ministério da Indústria, Comércio Exterior e Serviços—Instituto Nacional da Propriedade Industrial: Rio de Janeiro, Brasil, 2024.
  9. Dos Santos, G.S.; Miyasato, P.A.; Stein, E.M.; Colepicolo, P.; Wright, A.D.; Pereira, C.A.B.; Falkenberg, M.; Nakano, E. Algal-Derived Halogenated Sesquiterpenes from. Mar. Drugs 2022, 20, 111. [Google Scholar] [CrossRef]
  10. Pang, Z.; Lu, Y.; Zhou, G.; Hui, F.; Xu, L.; Viau, C.; Spigelman, A.; MacDonald, P.; Wishart, D.; Li, S.; et al. MetaboAnalyst 6.0: Towards a unified platform for metabolomics data processing, analysis and interpretation. Nucleic Acids Res. 2024, 52, W398–W406. [Google Scholar] [CrossRef]
  11. Adegboye, O.; Field, M.A.; Kupz, A.; Pai, S.; Sharma, D.; Smout, M.J.; Wangchuk, P.; Wong, Y.; Loiseau, C. Natural-Product-Based Solutions for Tropical Infectious Diseases. Clin. Microbiol. Rev. 2021, 34, e0034820. [Google Scholar] [CrossRef]
  12. Moreira-Filho, J.T.; Silva, A.C.; Dantas, R.F.; Gomes, B.F.; Souza Neto, L.R.; Brandao-Neto, J.; Owens, R.J.; Furnham, N.; Neves, B.J.; Silva-Junior, F.P.; et al. Schistosomiasis Drug Discovery in the Era of Automation and Artificial Intelligence. Front. Immunol. 2021, 12, 642383. [Google Scholar] [CrossRef]
  13. Neves, B.J.; Andrade, C.H.; Cravo, P.V. Natural products as leads in schistosome drug discovery. Molecules 2015, 20, 1872–1903. [Google Scholar] [CrossRef]
  14. Lombardo, F.C.; Pasche, V.; Panic, G.; Endriss, Y.; Keiser, J. Life cycle maintenance and drug-sensitivity assays for early drug discovery in Schistosoma mansoni. Nat. Protoc. 2019, 14, 461–481. [Google Scholar] [CrossRef]
  15. Matos-Rocha, T.J.; Lima, M.D.; Silva, A.L.; Oliveira, J.F.; Gouveia, A.L.; Silva, V.B.; Almeida, A.S.J.; Brayner, F.A.; Cardoso, P.R.; Pitta-Galdino, M.D.; et al. Synthesis and biological evaluation of novel imidazolidine derivatives as candidates to schistosomicidal agents. Rev. Inst. Med. Trop. Sao Paulo 2017, 59, e8. [Google Scholar] [CrossRef]
  16. Santiago Ede, F.; de Oliveira, S.A.; de Oliveira Filho, G.B.; Moreira, D.R.; Gomes, P.A.; da Silva, A.L.; de Barros, A.F.; da Silva, A.C.; Dos Santos, T.A.; Pereira, V.R.; et al. Evaluation of the anti-Schistosoma mansoni activity of thiosemicarbazones and thiazoles. Antimicrob. Agents Chemother. 2014, 58, 352–363. [Google Scholar] [CrossRef] [PubMed]
  17. Wang, X.; Yu, D.; Li, C.; Zhan, T.; Zhang, T.; Ma, H.; Xu, J.; Xia, C. In vitro and in vivo activities of DW-3-15, a commercial praziquantel derivative, against Schistosoma japonicum. Parasites Vectors 2019, 12, 199. [Google Scholar] [CrossRef]
  18. Lee, H.K.; Kim, M.K.; Kim, H.J.; Lee, J.O.; Kim, C.W.; Kim, E.E. Unique binding mode of evogliptin with human dipeptidyl peptidase IV. Biochem. Biophys. Res. Commun. 2017, 494, 452–459. [Google Scholar] [CrossRef]
  19. Ryu, Y.S.; Fernando, P.D.S.M.; Kang, K.A.; Piao, M.J.; Zhen, A.X.; Kang, H.K.; Koh, Y.S.; Hyun, J.W. Marine Compound 3-bromo-4,5-dihydroxybenzaldehyde Protects Skin Cells against Oxidative Damage via the Nrf2/HO-1 Pathway. Mar. Drugs 2019, 17, 234. [Google Scholar] [CrossRef]
  20. Augier, J. The chemical constitution of some red algae (Rhodomelaceae). Rev. Générale De Bot. 1953, 60, 257. [Google Scholar]
  21. Mikami, D.; Kurihara, H.; Kim, S.M.; Takahashi, K. Red algal bromophenols as glucose 6-phosphate dehydrogenase inhibitors. Mar. Drugs 2013, 11, 4050–4057. [Google Scholar] [CrossRef] [PubMed]
  22. Carvalho, L.R.; Fujii, M.T.; Roque, N.F.; Kato, M.J.; Lago, J.H.G. Aldingenin A, new brominated sesquiterpene from red algae Laurencia aldingensis. Tetrahedron Lett. 2003, 44, 2637–2640. [Google Scholar] [CrossRef]
  23. Carvalho, L.R.; Fujii, M.T.; Roque, N.F.; Lago, J.H. Aldingenin derivatives from the red alga Laurencia aldingensis. Phytochemistry 2006, 67, 1331–1335. [Google Scholar] [CrossRef] [PubMed]
  24. Kasanah, N.; Triyanto, T.; Seto, D.S.; Amelia, W.; Isnansetyo, A. Antibacterial Compounds from Red Seaweeds (Rhodophyta). Indones. J. Chem. 2015, 15, 201–209. [Google Scholar] [CrossRef]
  25. Suzuki, M.; Vairappan, C.S. Halogenated secondary metabolites from Japanese species of the red algal genus Laurencia (Rhodomelaceae, Ceramiales). Curr. Top. Phytochem. 2005, 7, 1–34. [Google Scholar]
  26. Brito, I.; Dias, T.; Díaz-Marrero, A.R.; Darias, J.; Cueto, M. Aplysiadiol from Aplysia dactylomela suggested a key intermediate for a unified biogenesis of regular and irregular marine algal bisabolene-type metabolites. Tetrahedron 2006, 62, 9655–9660. [Google Scholar] [CrossRef]
  27. Estrada, D.M.; Martín, J.D.; Pérez, R.; Rivera, P.; Rodríguez, M.L.; Ruano, J.Z. Furocaespitane and related C12 metabolites from Laurencia caespitosa. Tetrahedron Lett. 1987, 28, 687–688. [Google Scholar] [CrossRef]
  28. González, A.G.; Darias, V.; Estévez, E. Chemotherapeutic activity of polyhalogenated terpenes from Spanish algae. Planta Med. 1982, 44, 44–46. [Google Scholar] [CrossRef]
  29. De Souza Coração, A.C.; Gomes, B.A.; Chyaromont, A.M.; Lannes-Vieira, A.C.P.; Gomes, A.P.B.; Lopes-Filho, E.A.P.; Leitão, S.G.; Teixeira, V.L.; De Paula, J.C. How the Ecology of Calcified Red Macroalgae is Investigated under a Chemical Approach? A Systematic Review and Bibliometric Study. J. Chem. Ecol. 2024, 50, 593–609. [Google Scholar] [CrossRef]
  30. Lopes, C.; Obando, J.M.C.; Santos, T.C.D.; Cavalcanti, D.N.; Teixeira, V.L. Abiotic Factors Modulating Metabolite Composition in Brown Algae (Phaeophyceae): Ecological Impacts and Opportunities for Bioprospecting of Bioactive Compounds. Mar. Drugs 2024, 22, 544. [Google Scholar] [CrossRef]
  31. Kobayashi, J.; Kubota, T. Bioactive macrolides and polyketides from marine dinoflagellates of the genus Amphidinium. J. Nat. Prod. 2007, 70, 451–460. [Google Scholar] [CrossRef]
  32. Kubanek, J.; Jensen, P.R.; Keifer, P.A.; Sullards, M.C.; Collins, D.O.; Fenical, W. Seaweed resistance to microbial attack: A targeted chemical defense against marine fungi. Proc. Natl. Acad. Sci. USA 2003, 100, 6916–6921. [Google Scholar] [CrossRef]
  33. Rodríguez-Berríos, R.R.; Ríos-Delgado, A.M.; Perdomo-Lizardo, A.P.; Cardona-Rivera, A.E.; Vidal-Rosado, Á.; Narváez-Lozano, G.A.; Nieves-Quiñones, I.A.; Rodríguez-Vargas, J.A.; Álamo-Diverse, K.Y.; Lebrón-Acosta, N.; et al. Extraction, Isolation, Characterization, and Bioactivity of Polypropionates and Related Polyketide Metabolites from the Caribbean Region. Antibiotics 2023, 12, 1087. [Google Scholar] [CrossRef]
  34. Dias, D.A.; Urban, S.; Roessner, U. A Historical Overview of Natural Products in Drug Discovery. Metabolites 2012, 2, 303–336. [Google Scholar] [CrossRef]
  35. Gao, S.S.; Li, X.M.; Du, F.Y.; Li, C.S.; Proksch, P.; Wang, B.G. Secondary metabolites from a marine-derived endophytic fungus Penicillium chrysogenum QEN-24S. Mar. Drugs 2010, 9, 59–70. [Google Scholar] [CrossRef] [PubMed]
  36. Zhao, Q.; Chen, A.N.; Hu, S.X.; Liu, Q.; Chen, M.; Liu, L.; Shao, C.L.; Tang, X.X.; Wang, C.Y. Microalgal Microscale Model for Microalgal Growth Inhibition Evaluation of Marine Natural Products. Sci. Rep. 2018, 8, 10541. [Google Scholar] [CrossRef]
  37. Li, X.D.; Miao, F.P.; Yin, X.L.; Liu, J.L.; Ji, N.Y. Sesquiterpenes from the marine red alga Laurencia composita. Fitoterapia 2012, 83, 1191–1195. [Google Scholar] [CrossRef] [PubMed]
  38. Ahmad, T.B.; Rudd, D.; Kotiw, M.; Liu, L.; Benkendorff, K. Correlation between Fatty Acid Profile and Anti-Inflammatory Activity in Common Australian Seafood by-Products. Mar. Drugs 2019, 17, 155. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Chromatographic profile obtained by HPLC-MS in negative ionization mode of the polar partition (L. aldingensis—Hydromethanolic phase) and of the fractions obtained from the apolar partition—L. aldingensis—Hexane, L. aldingensis—Dichloromethane, L. aldingensis—Ethyl acetate, and L. aldingensis—Methanol. The numbers correspond to the peaks listed in Table 6. Peaks marked with (∗) representing contamination of the column.
Figure 1. Chromatographic profile obtained by HPLC-MS in negative ionization mode of the polar partition (L. aldingensis—Hydromethanolic phase) and of the fractions obtained from the apolar partition—L. aldingensis—Hexane, L. aldingensis—Dichloromethane, L. aldingensis—Ethyl acetate, and L. aldingensis—Methanol. The numbers correspond to the peaks listed in Table 6. Peaks marked with (∗) representing contamination of the column.
Pharmaceutics 17 01294 g001
Figure 2. Chromatographic profile obtained by HPLC-MS in negative ionization mode of the L. aldingensis—Dichloromethane fraction and its subfractions F1–F7. The numbers correspond to the peaks listed in Table 6. Peaks marked with (∗) representing contamination of the column.
Figure 2. Chromatographic profile obtained by HPLC-MS in negative ionization mode of the L. aldingensis—Dichloromethane fraction and its subfractions F1–F7. The numbers correspond to the peaks listed in Table 6. Peaks marked with (∗) representing contamination of the column.
Pharmaceutics 17 01294 g002
Figure 3. Pearson correlation analysis of the 25 hits selected in the LC-MS/MS analysis of Laurencia aldingensis fractions and schistosomicidal activity in Schistosoma mansoni. Black spots corresponding to the samples and yellow spots to the means. Peaks marked with (∗) representing hits.
Figure 3. Pearson correlation analysis of the 25 hits selected in the LC-MS/MS analysis of Laurencia aldingensis fractions and schistosomicidal activity in Schistosoma mansoni. Black spots corresponding to the samples and yellow spots to the means. Peaks marked with (∗) representing hits.
Pharmaceutics 17 01294 g003
Figure 4. Chromatographic profile by HPLC-DAD-MS in negative ionization mode of the polar partition (L. dendroidea—Hydromethanolic phase) and the fractions obtained from the apolar partition: L. dendroidea—Hexane, L. dendroidea—Dichloromethane, L. dendroidea—Ethyl acetate and L. dendroidea—Methanol. The numbers correspond to the peaks listed in Table 7. Peaks marked with (∗) representing contamination of the column.
Figure 4. Chromatographic profile by HPLC-DAD-MS in negative ionization mode of the polar partition (L. dendroidea—Hydromethanolic phase) and the fractions obtained from the apolar partition: L. dendroidea—Hexane, L. dendroidea—Dichloromethane, L. dendroidea—Ethyl acetate and L. dendroidea—Methanol. The numbers correspond to the peaks listed in Table 7. Peaks marked with (∗) representing contamination of the column.
Pharmaceutics 17 01294 g004
Figure 5. Chromatographic profile by HPLC-DAD-MS in negative ionization mode of the L. dendroidea Dichloromethane fraction and its subfractions F1—F7. The numbers correspond to the peaks listed in Table 7. Peaks marked with (∗) representing contamination of the column.
Figure 5. Chromatographic profile by HPLC-DAD-MS in negative ionization mode of the L. dendroidea Dichloromethane fraction and its subfractions F1—F7. The numbers correspond to the peaks listed in Table 7. Peaks marked with (∗) representing contamination of the column.
Pharmaceutics 17 01294 g005
Figure 6. Pearson correlation analysis of the 25 hits selected in the LC-MS/MS analysis of Laurencia dendroidea fractions and schistosomicidal activity in Schistosoma mansoni. Black spots corresponding to the samples and yellow spots to the means. Peaks marked with (∗) representing hits.
Figure 6. Pearson correlation analysis of the 25 hits selected in the LC-MS/MS analysis of Laurencia dendroidea fractions and schistosomicidal activity in Schistosoma mansoni. Black spots corresponding to the samples and yellow spots to the means. Peaks marked with (∗) representing hits.
Pharmaceutics 17 01294 g006
Table 1. Parameters used to construct the score.
Table 1. Parameters used to construct the score.
ParameterClassificationScore
Motility of each helminthNormal0
Slightly reduced1
Significantly reduced2
No movements3
Score = ∑ (M♀p + M♂p). M = motility score, p = time of exposure, ♀ = female; ♂ = male.
Table 2. Schistosomicidal effect of marine macroalgae Laurencia aldingensis Y. Saito and Womersley 1974 fractions on Schistosoma mansoni worms.
Table 2. Schistosomicidal effect of marine macroalgae Laurencia aldingensis Y. Saito and Womersley 1974 fractions on Schistosoma mansoni worms.
Concentration (µg/mL)FractionScoreClassification
100 µg/mLHydromethanolic phase16Poor
Methanol20Poor
Ethyl acetate10No effect
Dichloromethane120Good
Hexane115Good
75 µg/mLDichloromethane104Good
50 µg/mLDichloromethane50Regular
25 µg/mLDichloromethane20Poor
Positive controlPraziquantel 1.5 µg/mL123Good
Negative controlDMSO 1.5% µg/mL0No effect
Score track: No effect (0–10); Poor (11–37); Regular (38–80); Good (81–150).
Table 3. Schistosomicidal effect of marine macroalgae Laurencia dendroidea J. Agardh 1852 fractions on Schistosoma mansoni worms.
Table 3. Schistosomicidal effect of marine macroalgae Laurencia dendroidea J. Agardh 1852 fractions on Schistosoma mansoni worms.
Concentration (µg/mL)FractionScoreClassification
100 µg/mLHydromethanolic phase0No effect
Methanol22Poor
Ethyl acetate26Poor
Dichloromethane80Regular
Hexane139Good
75 µg/mLDichloromethane40Regular
50 µg/mLDichloromethane37Poor
25 µg/mLDichloromethane14Poor
Positive controlPraziquantel 1.5 µg/mL123Good
Negative controlDMSO 1.5% µg/mL0No effect
Score track: No effect (0–10); Poor (11–37); Regular (38–80); Good (81–150).
Table 4. Schistosomicidal effect of marine macroalgae Laurencia aldingensis Y. Saito and Womersley 1974 subfractions on Schistosoma mansoni worms.
Table 4. Schistosomicidal effect of marine macroalgae Laurencia aldingensis Y. Saito and Womersley 1974 subfractions on Schistosoma mansoni worms.
Concentration (µg/mL)SubfractionScoreClassification
100 µg/mLDCM—F10No effect
DCM—F20No effect
DCM—F30No effect
DCM—F4130Good
DCM—F5120Good
DCM—F616Poor
DCM—F716Poor
75 µg/mLDCM—F4120Good
DCM—F594Good
50 µg/mLDCM—F464Regular
DCM—F528Poor
25 µg/mLDCM—F40No effect
DCM—F50No effect
Positive controlPraziquantel 1.5 µg/mL120Good
Negative controlDMSO 1.5% µg/mL0No effect
Score track: No effect (0–10); Poor (11–37); Regular (38–80); Good (81–150).
Table 5. Schistosomicidal effect of marine macroalgae Laurencia dendroidea J. Agardh 1852 subfractions on Schistosoma mansoni worms.
Table 5. Schistosomicidal effect of marine macroalgae Laurencia dendroidea J. Agardh 1852 subfractions on Schistosoma mansoni worms.
Concentration (µg/mL)SubfractionScoreClassification
100 µg/mLDCM—F120Poor
DCM—F225Poor
DCM—F348Regular
DCM—F4120Good
DCM—F512Poor
DCM—F679Regular
DCM—F70No effect
75 µg/mLDCM—F355Regular
DCM—F466Regular
DCM—F624Poor
50 µg/mLDCM—F326Poor
DCM—F446Regular
DCM—F616Poor
25 µg/mLDCM—F34No effect
DCM—F426Poor
DCM—F620Poor
Positive controlPraziquantel 1.5 µg/mL120Good
Negative controlDMSO 1.5% µg/mL0No effect
Score track: No effect (0–10); Poor (11–37); Regular (38–80); Good (81–150).
Table 6. Chemical profile of Laurencia aldingensis Y. Saito and Womersley 1974 determined by HPLC-DAD-MS/MS.
Table 6. Chemical profile of Laurencia aldingensis Y. Saito and Womersley 1974 determined by HPLC-DAD-MS/MS.
PeakTR min.UVm/zFragmentationFormulaAnnotation
14.1 303.1926216(C10H18NO4)C14H28N2O5unknown
212.9 241.1215197(C10H17N2O2)C11H18N2O4unknown
313.2 189.0801---C8H14O5unknown
416.2255/285214.9379---C7H5BrO35-Bromo-3,4-dihydroxybenzaldehyde
519.2276198.9419---C7H5BrO23-Bromo-4-hydroxybenzaldehyde
623.1260292.8456248(C6H3Br2O)C7H4Br2O33,5-Dibromo-4-hydroxybenzoic acid
726.5277276.8443---C7H4Br2O23,5-Dibromo-4-hydroxybenzaldehyde
827.1---427.9923394(C17H15BrNO5). 348(C17H15ClNO5), 312(C17H14NO5)C17H17BrClNO5unknown
927.9---411.9981378(C17H15BrNO4). 332(C17H15ClNO4), 296(C17H14NO4)C17H17BrClNO4unknown
1029.0---354.9955275(C12H16ClO5), 239(C12H15O5)C12H18BrClO5unknown
1129.6---411.9973378(C17H15BrNO4). 332(C17H15ClNO4), 296(C17H14NO4). 209 (C11H13O4)C17H17BrClNO4unknown
1229.7---354.9951275(C12H16ClO5), 239(C12H15O5)C12H18BrClO5unknown
1330.6---252.9637---C8H12BrClO2unknown
1431.1---339.0016223(C12H15O4)C12H18BrClO4unknown
1531.2---223.1044---C12H16O4Terpene Derivative
1632.2---320.9906---C12H16BrClO3Furocaespitanelactol
1734.1---385.2052 C23H30O5unknown
1834.6 460.9659---C15H25Br2ClO4Aldingenin Derivative
1935.0---444.9751249(C14H17O4)C15H25Br2ClO3Aldingenin Derivative
2035.5---287.2244---C16H32O4Dihydroxypalmitic acid
2136.2---527.2520---C26H40O11unknown
2236.7---269.2137---C16H30O3Hydroxypalmitic acid
2337.7---488.9701---C16H25Br2ClO5Aldingenin Derivative
2437.8---490.9866---C16H27Br2ClO5Aldingenin Derivative
2538.4---555.2886225(C9H5O7)C28H44O11unknown
2638.8---533.0068269(C16H29O3)C22H29Br2ClO3unknown
2738.8---537.3304255(C16H31O2)C26H50O11unknown
2839.2---537.3323255(C16H31O2)C26H50O11unknown
2940.3---474.9910269(C16H29O3), 213(C13H25O2)C16H27Br2ClO4Aldingenin Derivative
3041.1---271.2286255(C15H29O)C16H32O3unknown
3141.5---340.2861310(C19H36NO2), 268 (C17H34NO)C20H39NO3unknown
3242.0---384.3129255(C16H31O2)C22H43NO4unknown
3342.3---384.3135255(C16H31O2)C22H43NO4unknown
3444.1---309.2428265(C18H34O)C19H34O3Hydroxy fatty acids derivative
3544.5---765.4752---C42H70O12putative Lobophorolide derivate
Table 7. Chemical profile of Laurencia dendroidea J. Agardh 1852 determined by HPLC-DAD-MS/MS.
Table 7. Chemical profile of Laurencia dendroidea J. Agardh 1852 determined by HPLC-DAD-MS/MS.
PeakTR min.m/zFragmentationFormulaAnnotation
14.17303.1925244, 216, 170C15H24N6OUnknown
218.38283.1548-C15H24O5Unknown
321.77283.1549211C11H20N6O3Unknown
426.41209.0853209C9H14N4SUnknown
529.67215.1282197, 169C11H20O4Unknown
631.11223.1010223C10H16N4SUnknown
731.43267.1600267, 249, 223C15H24O42,3,5,6,7,7a-Hexahydro-2,7-dihydroxy-3-(hydroxymethyl)-1,1,3,5-tetramethyl-1H-indene-4-carboxaldehyde
831.63393.0106397, 395, 393, 315, 313, 277, 233, 221C15H20BrClO5Hidroxy laurecomin D
932.26267.1594267, 223, 180C15H24O4Trichocarotin G
1032.66379.0311383, 381, 379, 299, 263, 221, 219C15H22BrClO4Laurecomin D
1133.76349.0211251, 193C14H20BrClO3Unknown
1234.85347.0049-C14H18BrClO3Unknown
1336.28527.2537225C23H44O11S2-Hydroxy-3-[(1-oxotetradecyl)oxy]propyl 6-deoxy-6-sulfo-α-D-glucopyranoside
1436.78601.2686225C29H46O11SUnknown
1537.04287.2229241, 223C16H32O4Unknown
1637.08285.2071267, 223, 183C16H30O4Unknown
1737.36317.2125317, 299, 255, 195, 167C20H30O3Unknown
1837.63653.3758397C31H58O14Unknown
1938.54319.2293319, 301, 257C20H32O3Hydroxyeicosatetraenoic acid
2038.54555.2853225C25H48O11S3-Hydroxy-2-[(1-oxohexadecyl)oxy]propyl 6-deoxy-6-sulfo-β-D-galactopyranoside
2138.55319.2281-C20H32O3Hydroxyeicosatetraenoic acid
2239.04313.2384313, 295, 225C18H34O4Penicitide A isomer
2339.06313.2384313, 295C18H34O4Penicitide A isomer
2439.34491.3218491, 255C25H48O92-Hydroxy-3-[(1-oxohexadecyl)oxy]propyl β-D-galactopyranoside
2539.59483.2735-C24H40N2O8Unknown
2640.13400.3064400C22H43NO5Unknown
2740.20474.9901-C16H27Br2ClO4Unknown
2841.66297.2442297, 251C18H34O3Unknown
2943.53327.2906327, 255C20H40O3Unknown
3043.86433.3328433C27H46O4Muristeroid G
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Soares, A.B.S.; Miyasato, P.A.; de Freitas, R.P.; Maleski, A.L.A.; Pimenta, D.C.; Colepicolo, P.; Stein, E.M.; Macedo, A.L.; Carollo, C.A.; Nakano, E. Use of Metabolomics Approach in the Discovery of Active Compounds from Macroalgae Laurencia Species Against Schistosomiasis. Pharmaceutics 2025, 17, 1294. https://doi.org/10.3390/pharmaceutics17101294

AMA Style

Soares ABS, Miyasato PA, de Freitas RP, Maleski ALA, Pimenta DC, Colepicolo P, Stein EM, Macedo AL, Carollo CA, Nakano E. Use of Metabolomics Approach in the Discovery of Active Compounds from Macroalgae Laurencia Species Against Schistosomiasis. Pharmaceutics. 2025; 17(10):1294. https://doi.org/10.3390/pharmaceutics17101294

Chicago/Turabian Style

Soares, Amanda Beatriz Silva, Patricia Aoki Miyasato, Rafaela Paula de Freitas, Adolfo Luis Almeida Maleski, Daniel Carvalho Pimenta, Pio Colepicolo, Erika Mattos Stein, Arthur Ladeira Macedo, Carlos Alexandre Carollo, and Eliana Nakano. 2025. "Use of Metabolomics Approach in the Discovery of Active Compounds from Macroalgae Laurencia Species Against Schistosomiasis" Pharmaceutics 17, no. 10: 1294. https://doi.org/10.3390/pharmaceutics17101294

APA Style

Soares, A. B. S., Miyasato, P. A., de Freitas, R. P., Maleski, A. L. A., Pimenta, D. C., Colepicolo, P., Stein, E. M., Macedo, A. L., Carollo, C. A., & Nakano, E. (2025). Use of Metabolomics Approach in the Discovery of Active Compounds from Macroalgae Laurencia Species Against Schistosomiasis. Pharmaceutics, 17(10), 1294. https://doi.org/10.3390/pharmaceutics17101294

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop